Invention Grant
- Patent Title: Agonistic anti-IL-2R antibodies and methods of use
-
Application No.: US18164442Application Date: 2023-02-03
-
Publication No.: US11884735B2Publication Date: 2024-01-30
- Inventor: Nathan Trinklein , Katherine Harris , Kyle Lorentsen , Harbani Kaur Malik Chaudhry , Kaitlyn Loughlin
- Applicant: TeneoBio, Inc.
- Applicant Address: US CA Thousand Oaks
- Assignee: TENEOBIO, INC.
- Current Assignee: TENEOBIO, INC.
- Current Assignee Address: US CA Thousand Oaks
- Agent Amy C. Madl
- Main IPC: C07K16/28
- IPC: C07K16/28 ; A61K39/00
Abstract:
Anti-IL2R (e.g., anti-IL2RB, anti-IL2RG, anti-IL2RB/G) antibodies are disclosed, along with methods of making such antibodies, compositions, including pharmaceutical compositions, comprising such antibodies, and use of such antibodies and compositions in the treatment of diseases and disorders that are mediated by the IL2/IL2R signaling pathway.
Public/Granted literature
- US20230242653A1 AGONISTIC ANTI-IL-2R ANTIBODIES AND METHODS OF USE Public/Granted day:2023-08-03
Information query
